Impact of the healthcare payment system on patient access to oral anticancer drugs: an illustration from the French and United States contexts
Author:
Publisher
Springer Science and Business Media LLC
Subject
Health Policy
Link
http://link.springer.com/article/10.1186/1472-6963-14-274/fulltext.html
Reference33 articles.
1. Weingart SN, Brown E, Bach PB, Eng K, Johnson SA, Kuzel TM, Langbaum TS, Leedy RD, Muller RJ, Newcomer LN, O'Brien S, Reinke D, Rubino M, Saltz L, Walters RS: NCCN task force report: oral chemotherapy. J Natl Compr Canc Netw. 2008, 6 (Suppl 3): S1-14.
2. Halfdanarson TR, Jatoi A: Oral cancer chemotherapy: the critical interplay between patient education and patient safety. Curr Oncol Rep. 2010, 12: 247-252. 10.1007/s11912-010-0103-6.
3. Banna GL, Collova E, Gebbia V, Lipari H, Giuffrida P, Cavallaro S, Condorelli R, Buscarino C, Tralongo P, Ferraù F: Anticancer oral therapy: emerging related issues. Cancer Treat Rev. 2010, 36: 595-605. 10.1016/j.ctrv.2010.04.005.
4. O’Neill VJ, Twelves CJ: Oral cancer treatment: developments in chemotherapy and beyond. Br J Cancer. 2002, 87: 933-937. 10.1038/sj.bjc.6600591.
5. Schott S, Schneeweiss A, Reinhardt J, Bruckner T, Domschke C, Sohn C, Eichbaum MH: Acceptance of oral chemotherapy in breast cancer patients - a survey study. BMC Cancer. 2011, 11: 129-10.1186/1471-2407-11-129.
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. The usage and costs of national drug price-negotiated anticancer medicines in a first-tier city in Northeast China: a study based on health insurance data;BMC Public Health;2024-05-14
2. How the National Health Insurance Coverage policy changed the use of lenvatinib for adult patients with advanced hepatocellular carcinoma: a retrospective cohort analysis with real world big data;International Journal for Equity in Health;2023-12-11
3. Quelle formation des savoirs sur le cancer et la chimiothérapie orale en contexte d’ETP ? Apports d’une approche psychosociale articulée à un dispositif de triangulation méthodologique;Psychologie Française;2023-09
4. How National Health Insurance Coverage Policy Changed the Use of Lenvatinib for Adult Patients with Advanced Hepatocellular Carcinoma: A Retrospective Cohort Analysis with Real World Big Data;2023-06-26
5. Trends in accessibility of negotiated targeted anti-cancer medicines in Nanjing, China: An interrupted time series analysis;Frontiers in Public Health;2022-07-22
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3